The Diary Of A CEO · 2026-06-15 · Darren Candow

Anti-Aging Expert: Creatine Is The Fat Loss Secret Doctors Don’t Tell You - Dr. Darren Candow

62 research-tied claims examined: 4 contradicted 10 overstated 3 context 43 supported 2 unverified

4 Contradicted by research
0:06:04Darren Candowcontradictedhigh

The human body naturally synthesizes 1 to 3 g of creatine per day only in the liver and brain, and stores 95% of total creatine in skeletal muscle.

"It is making about 1 to 3 g a day, but only in two areas. So, this will be quite shocking for people. We're only actually making it in the liver and the brain. We don't make it in skeletal muscle, but you store 95% in our muscle." (said at 0:06:04)

The speaker claimed that the body synthesizes creatine "only in two areas... only actually making it in the liver and the brain" and stores 95% in muscle. While it is true that ~95% of creatine is stored in skeletal muscle and that endogenous synthesis is ~1 to 2 g/day, the assertion that de novo synthesis occurs *only* in the liver and the brain is biochemically incorrect and contradicted by established human physiology. De novo synthesis of creatine requires a two-step inter-organ pathway: the first step is catalyzed by L-arginine:glycine amidinotransferase (AGAT), which takes place primarily in the kidneys (and pancreas) to produce guanidinoacetate (GAA); GAA is then transported to the liver (and other tissues), where guanidinoacetate N-methyltransferase (GAMT) methylates it to creatine. Thus, the kidneys are essential for the primary systemic biosynthetic pathway, contradicting the claim that synthesis happens only in the liver and brain.

0:09:30Darren Candowcontradictedmoderate

A creatine loading phase (20-30 g/day for 5-7 days) acutely increases water retention for 3-5 days, after which maintenance dosing of 3-5 g/day moves the water intracellularly into muscle.

"This is where supplement companies want you to take about 20 or 30 g a day for about 5 or 7 days. That has been shown to increase water retention acutely. So, maybe it'll reside there for about 3 to 5 days, but after that, when you go on a maintenance phase of about 3 to 5 g a day, that water retention goes away. So, in the initial stages, if done improperly or too much, it can cause a little bit of water retention. The good news for everybody watching is after about the first week, that water's inside our muscle." (said at 0:09:30)

The speaker misrepresents the physiology and timeline of creatine-induced fluid retention. Creatine is an osmotically active substance that is actively transported directly into skeletal muscle cells via sodium-dependent creatine transporters. As a result, creatine draws water intracellularly into muscle tissue immediately from the start of supplementation (including during the acute loading phase), rather than causing general extracellular water retention that later 'moves' intracellularly only once a maintenance phase begins. Randomized controlled trials evaluating fluid distribution after creatine loading (e.g., 20–25 g/day for 5–7 days) show that total body water increases primarily via proportional intracellular expansion, with no alteration in the ratio between fluid compartments or delay in muscle uptake.

0:12:45Darren Candowcontradictedhigh

The claim that creatine causes hair loss originated from a study in rugby players where 20-25 g/day for 7 days increased DHT within the normal biological range without measuring hair loss or thinning.

"This myth came from a study in rugby players decades ago where creatine about 20-25 g a day for 7 days increased a hormone called DHT. It's a precursor for testosterone, which unfortunately has been linked to hair follicle loss and thinning. But the ironic thing is when creatine was given to these young males, the hormone went up, but it was still within the biological range, and no measure of hair follicle thinning or loss was done." (said at 0:12:45)

The speaker accurately describes the origins of the creatine-hair loss myth from a 2009 randomized trial by van der Merwe et al. in 20 college-aged rugby players. In that study, 7 days of creatine loading (25 g/day) increased serum dihydrotestosterone (DHT) levels by 56% (remaining within normal clinical limits), and the study did not evaluate hair thinning or loss. However, the speaker states that DHT 'is a precursor for testosterone'. This biochemical relationship is inverted: testosterone is the precursor to DHT, with DHT being synthesized downstream from testosterone via the 5-alpha-reductase enzyme. Because the speaker states this mechanism backwards, the claim is graded as contradicted.

0:37:42Darren Candowcontradictedmoderate

Patients with Alzheimer's disease, clinical depression, and concussion have reduced baseline creatine levels in the brain.

"So, there's been populations Alzheimer's disease, clinical depression, concussion. When those populations are evident, one of the biggest factors is that they have reduced creatine in their brain." (said at 0:37:42)

Magnetic resonance spectroscopy (MRS) studies and meta-analyses show that total brain creatine is generally stable across conditions like Alzheimer's disease, concussion/mild traumatic brain injury (mTBI), and depression—so much so that creatine is routinely used as the internal reference standard (e.g., NAA/Cr ratio) against which other metabolites are measured. In traumatic brain injury and concussion, meta-analyses show consistent reductions in N-acetylaspartate (NAA), but creatine levels are largely unaffected. Similarly, in Alzheimer's disease, reductions are characteristically seen in NAA and increases in myo-inositol, not a uniform reduction in creatine.

10 Overstated
0:00:26Darren Candowoverstatedlow

At recommended dosages, creatine has potential anti-cancer properties, speeds up rehabilitation, and shows promise for Alzheimer's disease.

"So, for example, at recommended dosages, creatine can not only have potential anti-cancer properties, it really speed up rehabilitation, and there's a lot of hope, especially around Alzheimer's." (said at 0:00:26)

The speaker's assertions overstate the human evidence across all three domains: 1. Anti-cancer properties: Evidence is strictly preclinical (in vitro and murine models), where creatine has been shown to enhance CD8+ T-cell antitumor immunity and synergize with checkpoint inhibitors. However, preclinical models also show conflicting results, including promotion of metastasis in certain tumor types, and there are no clinical trials demonstrating anti-cancer efficacy in humans. 2. Rehabilitation: Creatine monohydrate has been shown to accelerate the recovery of muscle cross-sectional area and power during active resistance-based reloading after immobilization, but it does not consistently prevent atrophy during strict unloading, and clinical trial results across other rehabilitation settings (such as knee arthroplasty, stroke, or COPD) remain mixed or null. 3. Alzheimer's disease: Metabolic and cognitive improvements have been observed in transgenic Alzheimer's mouse models, but published clinical trials evaluating creatine supplementation for treating Alzheimer's disease in humans are currently lacking.

0:00:41Darren Candowoverstatedvery low

Scientific evidence suggests children should get at least 1 g of creatine per day to optimize bone health and muscle development.

"The current body of evidence suggests they want to get at least 1 g per day because in children they want to have optimization for bone health as well as muscle development." (said at 0:00:41)

The claim overstates preliminary, observational research as a formal dietary recommendation. Creatine is endogenously synthesized and is not considered an essential nutrient with an established dietary requirement in children. Cross-sectional analyses of NHANES survey data (e.g., Korovljev et al., 2021) found that higher dietary creatine intake (estimated from meat consumption) was correlated with higher lean mass, bone mineral content, and stature in youth, with average pediatric dietary intakes around 0.65 to 1.07 g/day. However, there are no randomized controlled trials or authoritative nutritional guidelines establishing that children need at least 1 g/day of creatine to optimize bone or muscle development.

0:11:53Darren Candowoverstatedmoderate

Meta-analyses show that creatine supplementation reduces fat mass while increasing lean mass, strength, endurance, and performance in females.

"When you go through the totality of all the evidence, females respond extremely robustly to creatine supplementation. They get profound benefits in strength, endurance, and performance. They lose a little bit of body fat. So, there's another idea that people thought water retention was causing an increase in in fat mass. We've done some meta-analysis now showing that creatine reduces fat mass. Females get an increase in lean mass as well." (said at 0:11:53)

Meta-analyses of randomized controlled trials demonstrate that creatine supplementation (when combined with resistance training) produces small improvements in lean body mass and muscular strength in females, along with small reductions in body fat percentage (-0.5% to -1.2%) or modest fat mass reduction (~0.5-0.7 kg). However, claiming that females respond 'extremely robustly' with 'profound benefits' is an overstatement; comparative meta-analyses show that gains in lean mass are generally smaller and less pronounced in females (+0.29 to +0.37 kg) than in males (+1.46 kg), and fat mass reductions are modest and conditional on structured exercise.

0:23:24Darren Candowoverstatedvery low

Creatine acts as a major methyl scavenger, and high doses spare methyl groups that are subsequently used to synthesize epinephrine/adrenaline.

"So, there is a mechanism, so creatine is the biggest methyl scavenger in the body and without boring your viewers, but methyl groups are used for everything. They're also used to synthesize something called adrenaline and our neurotransmitters... So, when you take in too much creatine, typically on an empty stomach or in a dehydrated state, that will spare methyl groups in the body to be used because you're taking so much in... these methyl groups are available in your body to go elsewhere to do work and they like to synthesize adrenaline." (said at 0:23:24)

The biochemical premise behind the speaker's claim is partially correct: endogenous creatine synthesis (via guanidinoacetate N-methyltransferase, GAMT) is quantitatively one of the largest consumers of S-adenosylmethionine (SAMe)-derived methyl groups in the body, and dietary creatine supplementation downregulates endogenous synthesis, thereby sparing methyl groups. Furthermore, the synthesis of epinephrine from norepinephrine via phenylethanolamine N-methyltransferase (PNMT) requires SAMe as a methyl donor. However, the assertion that spared methyl groups directly drive increased adrenaline synthesis is an unsupported mechanistic leap; catecholamine biosynthesis is tightly regulated and rate-limited by tyrosine hydroxylase and neuroendocrine stimulation, not driven purely by the availability of excess methyl groups.

0:26:58Darren Candowoverstatedlow

Creatine stimulates osteoblasts and reduces osteoclast activity, favorably altering bone turnover similarly to bisphosphonates.

"So, if you understand a 24-hour cycle that creatine sort of stimulates these bone-building cells to become more energized... And then on the flip side, creatine seems to decrease the osteoclasts, or bone breakdown cells. So, by a synergistic mechanism, it seems to cause this turnover to go a little bit better, causing the bone to maintain its structure. It's very similar to a bisphosphonate that someone would be taking to maintain their bone health." (said at 0:26:58)

While preclinical and in vitro research indicates that creatine provides an energy substrate to osteoblasts during differentiation and may influence bone turnover markers, equating dietary creatine to bisphosphonates is an overstatement. Bisphosphonates are potent pharmacological anti-resorptive drugs that bind avidly to hydroxyapatite and directly induce osteoclast apoptosis, whereas human trials of creatine monohydrate demonstrate only modest, conditional skeletal benefits (primarily when combined with resistance exercise) without pharmacological bisphosphonate-like efficacy or mechanism.

0:36:48Darren Candowoverstatedlow

Administering 20 g of creatine before and after a 90-minute Stroop test statistically significantly improved speed and cognitive performance.

"In this classic study they gave 20 g of creatine before they did the test and then after and it really improved their ability with speed and cognition there." (said at 0:36:48)

The speaker misstates the protocol and overstates the findings of the 2020 randomized crossover trial by Van Cutsem et al. (PMID: 31403610). Participants took 20 g/day of creatine for 7 days (not a dose before and after the test). While creatine supplementation statistically significantly improved accuracy during the 90-minute Stroop task (+4.9%), it did not improve visuomotor reaction speed or prevent the mental fatigue-induced decline in cognitive performance on the Flanker task. Meta-analytic evidence in adults (PMID: 39070254) also rates the overall certainty of creatine's effect on processing speed as low.

0:41:10Darren Candowoverstatedmoderate

Creatine supplementation decreases markers of muscle damage associated with weight training.

"From a weight training perspective, we see that it decreases markers of muscle damage." (said at 0:41:10)

Creatine supplementation is well-established for enhancing muscle strength and power during resistance training, but systematic evidence does not consistently demonstrate that it decreases biomarkers of muscle damage (such as creatine kinase or lactate dehydrogenase) or inflammatory markers. A systematic review and network meta-analysis of randomized trials in trained athletes (PMID: 41901084) found that creatine is superior for muscle strength (SMD = 0.46) but not the primary driver of recovery outcomes compared to other supplements like omega-3 fatty acids. Furthermore, a systematic review and meta-analysis of randomized placebo-controlled trials examining creatine's effects on systemic biomarkers (PMID: 41798953) found no significant reduction in inflammatory markers such as CRP or IL-6. While individual trials of eccentric exercise have reported mixed findings on post-exercise creatine kinase attenuation, claiming definitively that creatine decreases markers of muscle damage from weight training overstates the clinical trial evidence.

0:43:50HOSToverstatedlow

A study of over 200,000 adults found that individuals with the lowest dietary creatine intake had the highest rates of depressive symptoms.

"There was a study in Gatorade Sports Science Institute and which PubMed published that said a study of over 200,000 adults found that those who consumed the least amount of creatine in their daily diet had the highest rates of depressive symptoms." (said at 0:43:50)

The speaker references a well-known cross-sectional epidemiological analysis of NHANES data (published in Translational Psychiatry, 2020), which indeed found that individuals in the lowest quartile of dietary creatine intake had significantly higher rates of depressive symptoms compared to those in higher quartiles. However, the study included 22,692 adults—not 'over 200,000'. Additionally, the observational, cross-sectional design cannot establish causality or determine whether low dietary creatine causes depression.

  • partial: Dietary creatine intake and depression risk among U.S. adults. (Translational psychiatry 2020) · cited 90x in the literature
    "Patient health questionnaire, dietary creatine intake and covariates were obtained on 22,692 NHANES participants ≥20 years of age. Depression prevalence was calculated within quartiles of dietary creatine intake... Depression prevalence was 10.23/100 persons (95% CI: 8.64-11.83) among NHANES participants in the lowest quartile of dietary creatine intake compared with 5.98/100 persons (95% CI: 4.97-6.98) among participants in the highest quartile (p < 0.001)." (abstract, results)
    pubmedfull study (doi)
0:56:09Darren Candowoverstatedlow

Scientific reviews indicate that creatine supplementation is safe in adolescent children and teenagers and improves balance, agility, and body composition.

"Good researchers in the United States put out multiple reviews looking at creatine in adolescent children and teenagers. Improves balance, agility, body composition. If anything, they want to get at least 1 g per day because in children they want to have an optimization for bone health as well as muscle development... all the current reviews currently suggest that it's safe." (said at 0:56:09)

Scientific reviews (such as position stands and narrative reviews by US sports nutrition researchers) generally conclude that creatine supplementation has an acceptable safety profile with no significant adverse events reported across pediatric and adolescent studies (PMID: 33670822, PMID: 28615996). However, the claim overstates the strength and scope of the evidence. Systematic assessments note that studies in healthy adolescent athletes are small, of variable quality, lack long-term safety outcome trials, and show inconsistent results regarding athletic performance, agility, and body composition changes (PMID: 37008451). Furthermore, evidence establishing a specific 1 g/day requirement for adolescent bone and muscle optimization remains preliminary.

1:02:12Darren Candowoverstatedmoderate

Creatine supplementation has been shown to have beneficial effects on age-related muscle loss, strength loss, bone loss, and brain atrophy in older adults.

"when you go to an aging body and they're predisposed to age-related muscle loss, strength loss, functionality, bone loss, and atrophy in the brain, creatine has been shown to have effects there as well." (said at 1:02:12)

The speaker bundles multiple claims regarding creatine supplementation in older adults: beneficial effects on age-related muscle loss, strength loss, bone loss, and brain atrophy. While robust randomized controlled trials and meta-analyses support creatine's ability to improve lean muscle mass and muscular strength (primarily when combined with resistance training), the evidence for bone loss and brain atrophy is far weaker or absent. Meta-analyses of RCTs in older adults have found no significant effect of creatine supplementation on whole-body, hip, femoral neck, or lumbar spine bone mineral density compared to control. Regarding the brain, while preliminary trials and observational studies suggest potential modest benefits for certain cognitive domains (e.g., memory and attention), there is no evidence demonstrating that creatine reduces or prevents structural brain atrophy in aging humans.

3 Needs context
0:25:54Darren Candowneeds contextmoderate

Creatine supplementation at 8 to 12 g per day combined with resistance training reduces the rate of bone mineral density loss around the hip in postmenopausal females.

"The lowest dose ever has been shown to have bone benefits is 8 g all the way up to 12... where we've shown that about 8 to 12 g a day with exercise, and that's crucial. If you do not exercise, there's never been a study ever shown to have bone benefits, but if you do perform weightlifting, one of the very cool things in postmenopausal females is that creatine seemed to reduce the rate of bone mineral density loss around the hip region." (said at 0:25:54)

A 2015 randomized controlled trial by this research group (Chilibeck et al., PMID 25386713) did find that 12 months of creatine supplementation (0.1 g/kg/day, roughly 7–9 g/day) combined with resistance training attenuated femoral neck bone mineral density (BMD) loss (-1.2% vs -3.9% for placebo) in postmenopausal women. However, a subsequent larger 2-year RCT by the same group in 237 postmenopausal women (PMID 37144634) and a 2018 meta-analysis (PMID 29740583) found no statistically significant preservation of hip or femoral neck BMD compared with resistance training alone, although some geometric indicators of femoral bone strength were maintained.

0:28:31Darren Candowneeds contexthigh

The human brain weighs approximately 2 kg but consumes 20% of the body's daily resting energy.

"So, this organ is about 2 kg, but uses 20% of our daily energy at rest. So, just think about that. 20% of the amount of energy we're consuming from food or using is being used by the brain." (said at 0:28:31)

The speaker makes two main claims: (1) that the human brain accounts for approximately 20% of the body's daily resting energy/metabolic demand, and (2) that the organ weighs about 2 kg. The energetic claim is accurate and widely established in human physiology; the brain accounts for approximately 20% of the body's resting metabolic rate. However, the stated weight of 2 kg is an overestimate, as the average adult human brain typically weighs approximately 1.3 to 1.4 kg (roughly 2% of total body weight, which is commonly conflated with 2 kg).

0:56:45Darren Candowneeds contextmoderate

A study evaluating over 25,000 cases found that long-term creatine supplementation, even at doses exceeding 10 g per day, is safe and effective.

"Last year they put out a study looking at over 25,000 cases and creatine even over 10 g a day for many years has been very, very safe and effective." (said at 0:56:45)

The speaker appears to refer to large-scale reviews and evidence syntheses on creatine safety (such as the recent structured review and meta-analysis of 684 randomized trials involving over 12,800 participants in trial arms, or epidemiological datasets totaling tens of thousands of subjects), which demonstrate that creatine supplementation across diverse doses and durations does not significantly increase side effects or risks compared to placebo. However, no specific single study evaluating precisely 'over 25,000 cases' taking >10 g/day for 'many years' was identified; rather, the broad body of randomized and clinical evidence supports that creatine supplementation (including higher doses and long-term regimens) is well-tolerated, safe, and effective.

43 Supported by research
0:03:09Darren Candowsupportedhigh

Glutamine supplementation does not produce body composition improvements in young healthy individuals.

"I was doing my master's on an amino acid called glutamine, and at the time, about 20-30 years ago, glutamine was the biggest rage... And I sort of determined it was worthless in young healthy individuals from a body composition standpoint." (said at 0:03:09)

A systematic review and meta-analysis of clinical trials evaluating glutamine supplementation in athletes found that glutamine has no significant effect on body composition or lean body mass. Multiple randomized controlled trials in young, healthy adults undergoing resistance training similarly demonstrate no additional benefit of glutamine supplementation over placebo for improving lean tissue mass, muscle performance, or body composition.

0:06:36Darren Candowsupportedmoderate

Dietary creatine is found exclusively in animal flesh (red meat, seafood, and poultry), and vegans and vegetarians show the greatest response to creatine supplementation.

"The downfall though is they're not getting any dietary creatine, cuz creatine is only found in animal-based flesh. So, red meat, seafood, and poultry. They're naturally synthesizing about 1 to 2, maybe even 3 g a day through amino acids in their food, but vegans and vegetarians respond literally the best on the planet, because now they're taking in a supplement to allow that in." (said at 0:06:36)

Dietary creatine is found naturally almost exclusively in animal tissues (red meat, poultry, and fish/seafood), and humans endogenously synthesize approximately 1 to 2 g/day from amino acids (arginine, glycine, and methionine). Because vegetarians and vegans consume virtually no dietary creatine, their baseline tissue and blood creatine concentrations are lower than those of omnivores. Systematic reviews confirm that upon creatine supplementation, vegetarians and vegans experience substantial increases in muscle and blood creatine and phosphocreatine concentrations—often demonstrating greater relative and absolute tissue uptake and marked gains in lean mass and cognitive tests compared to omnivores, although findings on relative ergogenic exercise performance enhancements remain mixed.

0:08:12Darren Candowsupportedhigh

Creatine supplementation elevates serum creatinine levels without damaging kidney function, and randomized controlled trials show no detrimental renal effects.

"The problem is when individuals on creatine supplementation, they go to their doctor for their annual blood work, their creatinine might be a little bit elevated, and that's only from the breakdown of the compound... And there's been randomized control trials for several years showing that creatine causes no detrimental effects to the kidneys." (said at 0:08:12)

Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that creatine supplementation leads to a modest increase in serum creatinine levels due to the normal metabolic conversion of creatine to creatinine, rather than kidney impairment. When renal function is directly evaluated through actual glomerular filtration rate (GFR), estimated GFR (eGFR), or serum urea levels, creatine supplementation shows no detrimental effects on kidney function.

0:10:23Darren Candowsupportedmoderate

Intracellular muscle swelling caused by creatine water uptake stimulates cellular signaling pathways involved in muscle protein synthesis.

"Creatine is osmotic. Water likes to follow creatine, so by taking it into the muscle, it gets a lot bigger, and that's good because a swollen muscle stimulates protein synthesis to get bigger and stronger... when you're having or trapping water, it turns on all these signaling pathways that are involved in protein synthesis." (said at 0:10:23)

Creatine uptake into muscle cells increases intracellular osmolarity and water content (cellular swelling/hydration), which is well-documented to activate osmosensing mechanisms and anabolic signaling cascades. A double-blind, randomized crossover trial in humans demonstrated that short-term creatine monohydrate supplementation significantly increased total body water and upregulated mRNA and protein kinase expression involved in osmosensing, signal transduction, and protein synthesis regulation in skeletal muscle.

0:11:18Darren Candowsupportedhigh

A 6-week creatine supplementation study resulted in an average total body mass increase of only 0.86 kg, with the majority being lean mass.

"And this might come surprising, but if you did a 6-week study, pre and post after creatine, you only increase mass by 0.86 kg. And the majority of that is lean mass." (said at 0:11:18)

The speaker accurately cites the findings of a comprehensive 2024 GRADE-assessed systematic review and meta-analysis of 143 randomized controlled trials (Delpino et al., JISSN 2024). The meta-analysis found that creatine supplementation increased total body mass by a weighted mean difference of 0.86 kg (95% CI: 0.76 to 0.96 kg) and fat-free/lean mass by 0.82 kg (95% CI: 0.57 to 1.06 kg), demonstrating that the vast majority of the weight gained is lean mass.

0:13:16Darren Candowsupportedmoderate

A trial administering 5 g/day of creatine to young males during 6 to 8 weeks of resistance training found no detrimental effects on hair thinning or follicle loss.

"The cool thing is just a few years ago, they decided to put this theory to the test, and 5 g in young males for about 6 to 8 weeks of training caused no detrimental effect from hair thinning, follicle loss." (said at 0:13:16)

A 2025 randomized controlled trial directly evaluated the effect of daily creatine monohydrate supplementation (5 g/day) versus placebo over 12 weeks in 45 resistance-trained young males (ages 18–40). The investigators evaluated hair follicle metrics directly (hair density, follicular unit count, cumulative hair thickness via Trichogram and FotoFinder imaging) and serum androgens (DHT and testosterone). The trial found no significant differences between creatine and placebo groups in hair follicle health, hair growth parameters, or DHT levels, supporting the claim (with the minor distinction that the trial lasted 12 weeks rather than 6 to 8 weeks).

0:13:34Darren Candowsupportedmoderate

Creatine supplementation super-hydrates muscle cells and decreases the incidence of muscle cramps rather than causing them.

"Myth number five, creatine causes muscle cramps. No, I think this is so overplayed. When creatine is taken into the body and water will follow it, now you're super hydrating the muscle... But if anything, sodium decreases muscle cramps and it super hydrates. So, in the hotter environments, June, July, August, creatine is going to be one of your best friends." (said at 0:13:34)

Extensive sports nutrition research and prospective studies demonstrate that creatine supplementation does not cause muscle cramping or dehydration. Creatine increases intracellular water content (intracellular hydration/osmotic draw) and has been shown in athletic cohorts training in hot and humid environments to either decrease or not affect the incidence of muscle cramping and heat-related illness compared to non-users.

0:15:13Darren Candowsupportedmoderate

After stopping creatine supplementation, elevated creatine levels take about 4 weeks to return to baseline in skeletal muscle, and an estimated 5 weeks to 3 months in the brain.

"And in skeletal muscle, it takes about a month for those elevated levels to come back down. In the brain, we don't have a lot of evidence, but it's speculated it takes about anywhere between 5 weeks to about 3 months for those elevations to come back down." (said at 0:15:13)

Human clinical trials establish that following cessation of creatine loading/supplementation, skeletal muscle total creatine and phosphocreatine levels take approximately 4 weeks (~28 to 30+ days) to return to baseline levels. In the brain, uptake and clearance kinetics are considerably slower due to the blood-brain barrier, and as the speaker accurately caveats, direct evidence is limited and estimates for brain creatine washout are speculative, typically ranging from several weeks up to a few months.

0:16:43Darren Candowsupportedhigh

Creatine supplementation combined with resistance training increases lean mass by an average of about 1.2 kg.

"You get an increase in lean mass by about 1.2 kg. But as I said previously, remember only half of that is skeletal muscle." (said at 0:16:43)

Multiple systematic reviews and meta-analyses of randomized controlled trials evaluate the effect of creatine supplementation combined with resistance training on lean body mass (LBM). Recent meta-analyses consistently report an average additional increase of approximately 1.1 to 1.4 kg of lean mass over resistance training alone (e.g., Desai et al. [2024] found an increase of 1.14 kg [95% CI: 0.69 to 1.59 kg]; Dos Santos et al. [2022] found a mean difference of 1.10 kg [95% CI: 0.56 to 1.65 kg]; and Devries et al. [2017] found an increase of 1.37 kg [95% CI: 0.97 to 1.76 kg] in older adults).

0:17:15Darren Candowsupportedmoderate

Creatine reduces muscle protein breakdown, aiding in muscle recovery and structural integrity.

"I think one of the big things is that it decreases something called protein breakdown. So, that might allow the muscle to maintain its integrity or recover quicker." (said at 0:17:15)

Creatine supplementation has been shown to exert anti-catabolic effects, attenuate markers of muscle damage and protein degradation, and enhance post-exercise recovery and structural integrity. Scientific position stands and mechanistic reviews note that creatine supplementation helps reduce muscle damage, preserve muscle integrity, and accelerate rehabilitation and recovery following strenuous exercise or disuse.

0:20:18Darren Candowsupportedhigh

No newly marketed form of creatine, such as creatine hydrochloride, has been proven to be safer or more effective than creatine monohydrate.

"All the evidence that you ever hear about the safety and efficacy of creatine is based on the old, boring, from 1832 creatine monohydrate. There's new marketed forms of creatine such as hydrochloride, which does have evidence behind it. There's many other forms, but the only downfall with all these marketed forms is it's never been shown to be safer or more effective than creatine monohydrate." (said at 0:20:18)

Comprehensive reviews and clinical trials evaluating various marketed and novel formulations of creatine (including creatine hydrochloride, creatine ethyl ester, buffered creatine, and creatine nitrate) confirm that none have been demonstrated to be more bioavailable, more effective, or safer than creatine monohydrate.

0:00:41Darren Candowsupportedhigh

Creatine was discovered in the year 1832.

"And so, I'm fascinated that this nutrient, discovered in 1832, like boring for the longest time as having these profound benefits we never even thought would happen." (said at 0:00:41)

The claim is accurate. Creatine was first discovered and isolated from skeletal muscle meat in 1832 by the French chemist Michel Eugène Chevreul.

0:22:21Darren Candowsupportedmoderate

Intramuscular creatine levels in the lower limbs decline with advancing age.

"Because as we get older, the creatine in our lower legs is more jeopardized, and therefore you might need a bit more." (said at 0:22:21)

The speaker's statement that intramuscular creatine in the lower limbs declines or is compromised with advancing age is supported by the physiological literature on aging and sarcopenia. Biological aging is characterized by preferential atrophy of glycolytic Type II muscle fibers (which store higher concentrations of creatine and phosphocreatine) and reductions in resting intramuscular total creatine and phosphocreatine levels in lower-limb muscles (such as the vastus lateralis and gastrocnemius). Narrative reviews and clinical evaluations consistently document these age-related declines and identify them as the primary physiological rationale for creatine supplementation to support lower-body muscle mass, strength, and function in older adults.

0:25:54Darren Candowsupportedmoderate

Creatine supplementation has never been shown in scientific studies to provide bone health benefits without concurrent exercise training.

"If you do not exercise, there's never been a study ever shown to have bone benefits, but if you do perform weightlifting, one of the very cool things in postmenopausal females is that creatine seemed to reduce the rate of bone mineral density loss around the hip region." (said at 0:25:54)

The speaker accurately summarizes the clinical evidence regarding creatine and bone health. Without concurrent resistance training, trials of creatine supplementation have not demonstrated measurable benefits on bone mineral density or bone structure. When combined with resistance training in postmenopausal women, a 12-month randomized controlled trial (Chilibeck et al., 2015) demonstrated that creatine supplementation significantly attenuated the rate of bone mineral density loss at the femoral neck (hip region) compared to placebo (-1.2% vs. -3.9%). Subsequent meta-analyses confirm that lean mass and functional improvements require concurrent resistance training and that bone density effects do not occur without exercise.

0:29:49Darren Candowsupportedmoderate

Circulating creatine has limited permeability and poorly crosses the blood-brain barrier.

"So unfortunately for the brain, creatine really struggles to get through the blood-brain barrier. But if it does, now you might need longer or higher dosages." (said at 0:29:49)

The speaker's statement accurately reflects established physiological understanding of creatine transport into the central nervous system. The blood-brain barrier (BBB) exhibits low permeability to circulating creatine because the creatine transporter (SLC6A8) is expressed on microcapillary endothelial cells but is absent from the astrocyte end-feet surrounding them. Consequently, creatine crosses the BBB with limited efficiency, requiring high doses and prolonged supplementation protocols to increase brain creatine levels, while the brain relies heavily on its own endogenous synthesis.

0:30:36Darren Candowsupportedmoderate

Brain MRI studies indicate that an acute dose of about 20 g of creatine shows an effect on the brain.

"The best overall studies currently right now that use an MRI for the brain have showed about 20 g seems to have some effect acutely." (said at 0:30:36)

Human neuroimaging studies using magnetic resonance spectroscopy (MRS, a specialized magnetic resonance technique) have demonstrated acute neurometabolic effects following a single high dose of creatine (~0.35 g/kg, which equals approximately 20–28 g in adults). Specifically, under acute metabolic stress such as sleep deprivation, single-dose creatine supplementation was shown to rapidly alter high-energy phosphate bioenergetics (such as phosphocreatine ratios and ATP dynamics) in the brain.

0:30:48Darren Candowsupportedmoderate

A study in Germany showed that giving a 30 g acute dose of creatine to young individuals sleep-deprived for 21 hours increased brain creatine levels and offset negative effects.

"So a classic study was done last year when they gave 30 g to a group of young individuals who volunteered to be sleep deprived for 21 hours. And that level of creatine increased creatine levels in the brain and it offset some of the negative effects." (said at 0:30:48)

The claim accurately describes a 2024 study by Gordji-Nejad et al. conducted in Germany. Healthy young participants underwent 21 hours of sleep deprivation and received an acute high dose of creatine monohydrate (0.35 g/kg, which corresponds to approximately 25–30 g for average body weights). Magnetic resonance spectroscopy demonstrated acute changes in cerebral high-energy phosphates and total creatine (tCr/tNAA), alongside significant improvements in processing speed and cognitive performance, mitigating fatigue-induced deterioration.

0:31:06Darren Candowsupportedmoderate

A subsequent sleep-deprivation study using a lower creatine dose of approximately 0.2 g/kg (or 14 g) did not produce the same beneficial brain effects as the 30 g dose.

"They've done a subsequent study going down to about 0.2 g or about 14 g. It didn't have the same effect." (said at 0:31:06)

A subsequent randomized trial by the same research group evaluated a lower single dose of creatine (0.2 g/kg, approximately 14 g for a 70 kg individual) during 21 hours of sleep deprivation compared to their original 0.35 g/kg (~25-30 g) protocol. The researchers found that while 0.2 g/kg still significantly mitigated cognitive deterioration (showing improvements of up to 12% in tasks like logic, numerical processing, and psychomotor vigilance), the effect was less pronounced than with the higher 0.35 g/kg dose.

0:40:45Darren Candowsupportedlow

Athletes who took 20 g of creatine per day for 5 days prior to an Ironman triathlon exhibited reductions in inflammatory markers.

"But when you do Ironman triathlon, things like that, those individuals who took creatine 20 g a day for 5 days beforehand, they had reductions in inflammation markers." (said at 0:40:45)

The claim accurately reflects the findings of a double-blind randomized controlled trial by Santos et al. (2008), in which triathletes taking 20 g/day of creatine for 5 days prior to a half-Ironman competition experienced significantly attenuated post-race increases in inflammatory markers (TNF-alpha, INF-alpha, IL-1beta, and PGE2) compared to a carbohydrate placebo group. The GRADE certainty is rated low due to the very small sample size (n = 11 total).

0:41:24Darren Candowsupportedvery low

Single-arm studies by Matt Taylor and Aaron Smith showed that 20 g per day of creatine for 8 weeks increased brain creatine levels and improved memory and cognition in Alzheimer's patients.

"a couple of single arm studies came out last year by Matt Taylor and Aaron Smith showing that 20 g a day for 8 weeks did increase brain creatine levels in Alzheimer's patients and it seemed to improve measures of memory and cognition there as well." (said at 0:41:24)

The speaker accurately describes the findings and design of the pilot trial led by Matthew Taylor and colleagues (the CABA study, NCT05383833). In this single-arm pilot trial of 20 patients with Alzheimer's disease taking 20 g/day of creatine monohydrate for 8 weeks, magnetic resonance spectroscopy showed an 11% increase in brain total creatine (p < .001), alongside improvements in composite cognitive scores (global and fluid composites) and working memory (List Sorting test). As an uncontrolled, open-label single-arm pilot study with a small sample size (n=20), the certainty of evidence for therapeutic efficacy is very low.

  • supports: Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition. (Alzheimer's &amp; dementia (New York, N. Y.) 2025) · cited 13x in the literature
    "In this single-arm pilot trial, we investigated the feasibility of 20 g/day CrM for 8 weeks in 20 patients with AD. We measured compliance throughout; serum creatine at baseline, 4 weeks, and 8 weeks; and brain total creatine (tCr) and cognition (National Institutes of Health [NIH] Toolbox, Mini-Mental State Examination [MMSE]) at baseline and 8 weeks. Nineteen participants achieved the target of ≥80% compliance with the CrM intervention. Serum Cr was elevated at 4 and 8 weeks ( p < .001) and brain tCr increased by 11% ( p < .001). Cognition improved on global ( p = .02) and fluid ( p = .004) composites, List Sorting ( p = .001), Oral Reading ( p < .001), and Flanker ( p = .05) tests." (abstract, results)
    pubmedfull study (doi)
0:42:16HOSTsupportedlow

A landmark study of 20 Alzheimer's patients taking 20 g of creatine daily for 8 weeks increased brain creatine levels by 11%, increased hand grip strength by 1.9 kg, and significantly improved cognitive test scores.

"There was an 8-week trial in Alzheimer's patients that also showed modest muscle gains and a 1.9 kg increase in hand grip strength, which is a key predicator of survival in dementia patients, which was a landmark study of 20 Alzheimer's patients found that taking 20 g of creatine daily for 8 weeks increased brain creatine levels by 11% and significantly improved the cognitive test scores they showed." (said at 0:42:16)

The speaker accurately describes the results of an open-label, single-arm pilot trial (the CABA study) in 20 patients with Alzheimer's disease taking 20 g/day of creatine monohydrate for 8 weeks. Published reports from this trial confirmed an 11% increase in brain total creatine (p < 0.001), significant improvements in several cognitive test batteries, a mean 1.9 kg increase in dominant handgrip strength (p = 0.02), and modest gains in muscle cross-sectional area. Because the study was a small, uncontrolled pilot without a placebo group, the certainty of evidence for clinical efficacy is low.

0:43:08Darren Candowsupportedmoderate

Adding creatine as an adjunct to SSRIs, cognitive behavioral therapy, or methamphetamine addiction treatment improves clinical depressive and anxiety symptoms.

"The group out of Utah in the United States have clearly shown that creatine in addition to other therapies—so this is important: Creatine by itself has never been shown to be a stand-alone, but with SSRIs or cognitive behavior therapy or methamphetamine use in populations under medical supervision, the addition of creatine seemed to improve symptoms" (said at 0:43:08)

Published clinical trials—notably from researchers at the University of Utah (such as Perry Renshaw and colleagues)—support the finding that creatine supplementation adjunct to other therapies improves depressive and anxiety symptoms. Specifically, a randomized controlled trial found that creatine monohydrate augmentation of escitalopram (an SSRI) significantly accelerated and improved antidepressant response compared to placebo in women with major depressive disorder. An open-label pilot study in females with depression and comorbid methamphetamine dependence found that adjunctive creatine significantly decreased both depression (HAM-D) and anxiety (BAI) scores. Additionally, clinical trials have shown that adjunctive creatine monohydrate enhances the efficacy of cognitive behavioral therapy (CBT) for depressive symptoms compared to CBT plus placebo.

0:43:38Darren Candowsupportedvery low

Creatine supplementation has been shown in animal models to increase levels of brain-derived neurotrophic factor (BDNF).

"but it also in animals has been shown to improve a protein called BDNF. So this protein is involved in brain plasticity." (said at 0:43:38)

The speaker accurately states that creatine supplementation has been demonstrated in animal models to increase brain-derived neurotrophic factor (BDNF), a protein involved in neuroplasticity. Preclinical rodent studies and a 2026 systematic review confirm that creatine administration upregulates hippocampal BDNF mRNA expression and protein levels alongside other markers of synaptic plasticity. Because the evidence is derived exclusively from animal experiments, GRADE certainty is very low.

0:44:28HOSTsupportedmoderate

In a clinical trial of women with major depression, adding 5 g of creatine daily to an antidepressant doubled the remission rate over 8 weeks.

"In a clinical trial of women with major depression, adding 5 g of creatine to their daily antidepressant doubled their remission rate over 8 weeks." (said at 0:44:28)

The claim accurately describes an 8-week, randomized, double-blind, placebo-controlled trial by Lyoo et al. (2012; PMID 22864465) in 52 women with major depressive disorder receiving escitalopram. Patients were randomized to receive 5 g/day of creatine monohydrate or placebo. Patients receiving creatine augmentation showed significantly greater reductions in HAM-D scores starting at week 2 through week 8 (at week 8, remission was achieved in ~52% of the creatine group vs ~26% of the placebo group, approximately doubling the remission rate). Certainty is moderate due to the small sample size (n=52) from a single randomized trial.

  • supports: A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentat… (The American journal of psychiatry 2012) · cited 130x in the literature
    "Fifty-two women with major depressive disorder were enrolled in an 8-week double-blind placebo-controlled clinical trial and randomly assigned to receive escitalopram in addition to either creatine (5 g/day, N=25) or placebo (N=27). Efficacy was primarily assessed by changes in the Hamilton Depression Rating Scale (HAM-D) score. In comparison to the placebo augmentation group, patients receiving creatine augmentation showed significantly greater improvements in HAM-D score, as early as week 2 of treatment. This differential improvement favoring creatine was maintained at weeks 4 and 8." (abstract, methods and results, passage verified)
    pubmedfull study (doi)
0:45:04Darren Candowsupportedhigh

Herring, salmon, and beef contain the highest natural concentrations of creatine, whereas milk and dairy contain only very small amounts.

"They're primarily animal based, so seafood and red meat. You know, herring is going to have one of the highest concentrations, salmon, as well as beef. Very small amounts in milk and dairy" (said at 0:45:04)

Dietary creatine is found almost exclusively in animal tissues, with muscle meats (such as fish and red meat, including herring, salmon, and beef) containing the highest natural concentrations (typically ~3–10 g/kg). In contrast, non-muscle animal foods like milk and dairy contain only minimal trace amounts (~0.1 g/kg). Published nutritional literature confirms that meat and fish are the primary dietary sources of creatine, whereas plant-based diets lack creatine entirely.

0:45:33Darren Candowsupportedmoderate

A study in young, healthy females found that taking 5 g of creatine daily resulted in sleeping an average of 1 hour longer on training days compared to placebo.

"One of them was young athletes who took 5 g of creatine daily slept an average of 1 hour longer on training days. GUEST1: Yeah, we did that study a few years ago in young biological females who were healthy. And on the days that they trained and took creatine, this is interesting because they actually slept an hour longer compared to the placebo." (said at 0:45:33)

A double-blind, randomized controlled trial in 21 naturally menstruating females (PMID 39203908) evaluated daily supplementation of 5 g of creatine (plus 5 g maltodextrin) versus placebo for 6 weeks alongside resistance training twice weekly. Sleep duration, tracked using an Oura ring, showed a statistically significant increase in total sleep duration following resistance training days in the creatine group compared to placebo, directly supporting the guest's statement.

0:48:31Darren Candowsupportedhigh

Lifting lighter weights performed with high effort near fatigue produces the same increases in muscle mass as lifting heavy weights.

"lighter weights if performed to a lot of effort, almost to fatigue, if done correctly, you can get the same increases in muscle mass as then compared to lifting heavy weights." (said at 0:48:31)

Multiple systematic reviews and meta-analyses of randomized experimental trials demonstrate that resistance training with lower loads (lighter weights) performed with high effort or to failure produces similar muscle hypertrophy compared to training with heavy loads. While heavy loads produce superior adaptations in 1-repetition maximum (1RM) strength, hypertrophic adaptations are equivalent across a wide spectrum of loading ranges when sets are taken close to muscular failure.

0:50:33Darren Candowsupportedhigh

Performing whole-body resistance training 2 days per week is sufficient to achieve musculoskeletal maintenance and benefits.

"Now, when it comes to weight training, this might be surprising, but 2 days a week or more is all you basically need and you can do a whole body routine." (said at 0:50:33)

Systematic reviews and Bayesian network meta-analyses of randomized trials demonstrate that resistance training performed at a frequency of 2 days per week (e.g., via whole-body routines where major muscle groups are trained twice weekly) provides substantial musculoskeletal benefits, including significant increases in muscle strength and hypertrophy compared to non-exercise controls, and is sufficient for muscle maintenance and adaptation.

0:51:27Darren Candowsupportedmoderate

Sedentary adults lose muscle mass at an accelerated rate of approximately 1% per year after age 40, and lose muscle strength at 1% to 3% per year.

"You're losing muscle mass at an accelerated rate. On average, it's about 1% per year after the age of 40... This is the average sedentary inactive population. You lose strength at about 1 or 1 to 3% even faster." (said at 0:51:27)

The speaker's statement accurately reflects established epidemiological and physiological findings regarding age-related sarcopenia and dynapenia. Longitudinal cohort data and narrative reviews establish that muscle mass decline begins around the fifth decade of life (age 40–50) at an average rate of roughly 0.5% to 1.2% (~1%) per year, while muscle strength declines at a faster rate of approximately 1% to 3% (or ~3%+) per year in older and sedentary adults.

0:52:35Darren Candowsupportedmoderate

Combining high-quality protein supplementation with creatine increases lean tissue mass and muscle performance more than either supplement alone.

"So, there's been a few studies when you combine a high quality protein with creatine, they have been shown to increase lean tissue mass and muscle performance a little bit more than each alone, yeah." (said at 0:52:35)

Multiple randomized controlled trials and meta-analytic evidence show that co-ingesting high-quality protein (such as whey) with creatine monohydrate during resistance training can produce modestly greater increases in lean tissue mass and upper-body strength (e.g., bench press 1RM) compared to supplementing with either protein, creatine, or placebo alone. The speaker accurately qualified this additive benefit as being demonstrated in a few studies and yielding 'a little bit more' gains.

0:53:04Darren Candowsupportedmoderate

A protein intake of 1.2 to 1.6 g per kilogram of body weight is sufficient for health benefits in most people.

"I think if you're getting about 1.2 to 1.6 g per kilogram. So, you know, if you're 70 kg, that's going to be on average about 84 to about 115 g of protein. I think we're so conscious now of the health benefits of protein that most people are." (said at 0:53:04)

Scientific reviews and meta-analyses support the target of 1.2 to 1.6 g/kg/day of protein for health benefits in adults, exceeding the standard Recommended Dietary Allowance (RDA) minimum of 0.8 g/kg/day. Intakes in the 1.2 to 1.6 g/kg range have been shown to optimize muscle protein synthesis, support lean body mass maintenance or gains (particularly with resistance exercise or in aging populations), improve satiety, and support weight management.

0:57:40Darren Candowsupportedmoderate

A study showed that consuming 1 g of creatine every 30 minutes up to a 20 g total dose resulted in greater bodily creatine retention than a bolus dose.

"And if anything, there's been a study a few years ago showing that 1 g every 30 minutes up to 20 g dose seemed to retain more in the body and that was beneficial as well." (said at 0:57:40)

A crossover trial in 9 healthy men (Sale et al., 2009) compared 20 x 1 g/day (taken at frequent intervals during the day) against standard loading (4 x 5 g/day) of creatine monohydrate for 5 days. Total urinary excretion of creatine was significantly lower on the 20 x 1 g regimen (49.25 g vs. 62.32 g), reflecting higher estimated total body retention. Certainty is moderate due to the small sample size.

0:59:45Darren Candowsupportedmoderate

A landmark 1992 study demonstrated that a 5 g dose of creatine elevated blood creatine levels and multiple 5 g doses maintained elevated levels throughout the day.

"So the landmark study came out in 1992 and it clearly showed that 5 g elevated creatine in the blood. But if you took multiple 5 g dosages it maintained that throughout the day." (said at 0:59:45)

The landmark 1992 study by Harris et al. tested creatine supplementation in human subjects and demonstrated that an oral 5 g dose of creatine monohydrate resulted in a marked elevation of plasma creatine (peaking at a mean of 795 µmol/l after 1 hour), and that repeated 5 g doses (every 2 hours) sustained blood creatine concentrations at around 1000 µmol/l throughout the day.

1:00:00Darren Candowsupportedhigh

Taking 3 g of creatine daily for 1 month fully saturates muscle creatine stores.

"So 3 g seems to be the lowest most effective dose and you just need to take that for 1 month and you'll saturate your muscles." (said at 1:00:00)

The claim is supported by landmark clinical trials evaluating skeletal muscle creatine accumulation via muscle biopsy. In a foundational study by Hultman et al. (1996), supplementing with 3 g of creatine per day for 28 days produced an approximate 20% increase in total intramuscular creatine stores, achieving the same level of muscle saturation as a rapid loading protocol (20 g/day for 6 days).

  • supports: Muscle creatine loading in men. (Journal of applied physiology (Bethesda, Md. : 1985) 1996) · cited 815x in the literature
    "A similar, but more gradual, 20% increase in muscle total creatine concentration was observed over a period of 28 days when supplementation was undertaken at a rate of 3 g/day. In conclusion, a rapid way to "creatine load" human skeletal muscle is to ingest 20 g of creatine for 6 days. This elevated tissue concentration can then be maintained by ingestion of 2 g/day thereafter. The ingestion of 3 g creatine/day is in the long term likely to be as effective at raising tissue levels as this higher dose." (abstract, results, passage verified)
    pubmedfull study (doi)
1:00:15Darren Candowsupportedhigh

A 2-year trial in postmenopausal women administering 0.14 g/kg of creatine showed preserved bone and improved muscle performance.

"we did was the 2-year trial in postmenopausal women where we gave 0.14 g of creatine and it really seemed to improve or have an effect on bone preservation as well as muscle performance." (said at 1:00:15)

A 2-year randomized controlled trial by Candow et al. (2023) evaluated 237 postmenopausal women randomized to receive creatine monohydrate (0.14 g/kg/day) or placebo alongside resistance and walking exercise. Although creatine had no significant effect on areal bone mineral density (BMD), it significantly preserved bone geometric properties predictive of bone bending strength (section modulus and buckling ratio) at the femoral neck. In addition, creatine improved physical/functional performance (reducing 80-meter walking time) and increased lean tissue mass in completers.

0:55:04Darren Candowsupportedvery low

Animal cell studies show that estrogen is directly involved in creatine metabolism and is implicated in the enzymes required to synthesize creatine.

"We know from animal cells that estrogen is highly involved in creatine metabolism. Estrogen seems to be implicated in the enzymes that are needed to make creatine." (said at 0:55:04)

The claim accurately describes preclinical and narrative review findings regarding the hormonal regulation of creatine metabolism. Animal and cell-based literature demonstrates that ovarian hormones (specifically estrogen and progesterone) influence creatine kinase activity as well as the expression and activity of the enzymes involved in endogenous creatine synthesis (such as arginine:glycine amidinotransferase [AGAT] and guanidinoacetate N-methyltransferase [GAMT]), leading to cyclical fluctuations in creatine kinetics. Because the underlying evidence cited is derived primarily from animal, in vitro, and preclinical mechanistic models, the certainty of evidence for direct clinical translation remains very low.

0:47:53Darren Candowsupportedhigh

Resistance training performed effectively can improve mitochondrial health and increase VO2 max.

"Weight training if done effectively can actually improve mitochondrial health. You can actually improve VO2 max if done correctly and you don't need a lot of it." (said at 0:47:53)

Published randomized clinical trials and systematic reviews/meta-analyses support that resistance (weight) training improves cardiorespiratory fitness (including VO2 max) and enhances mitochondrial capacity/bioenergetics, particularly in sedentary or untrained individuals. For example, a network meta-analysis of 51 randomized controlled trials demonstrated significant improvements in VO2 max following strength training protocols.

0:58:08Darren Candowsupportedmoderate

A randomized controlled trial showed that creatine gummies produced performance improvements in volleyball players.

"They're the first company that actually look at randomized control trial to show improvements in volleyball players with the gummies." (said at 0:58:08)

A 10-week randomized controlled trial evaluated creatine monohydrate supplementation delivered in gummy form (5 g/day) in 32 female collegiate and professional beach volleyball athletes. The trial found significant performance improvements in countermovement jump height (p < 0.001) and change-of-direction speed (p = 0.009) compared to controls.

1:01:42Darren Candowsupportedmoderate

NAD levels decline with aging.

"NAD. This is the you know, it's a precursor for a main enzyme that's highly involved in metabolism. There's been evidence to suggest it goes down with aging" (said at 1:01:42)

The speaker's cautious statement that 'there's been evidence to suggest it goes down with aging' is supported. Preclinical animal models and several human tissue studies have consistently demonstrated age-related decreases in NAD+ concentrations and biosynthesis. However, human evidence is tissue-dependent, and recent large-cohort studies indicate that while tissue-level declines are widely documented, whole-blood NAD+ levels may remain relatively stable across age.

1:02:43Darren Candowsupportedvery low

In animal models, creatine has been shown to have beneficial effects on fat from a cellular perspective.

"And then in animal models, it has been shown to have some beneficial effects from a cellular perspective on fat" (said at 1:02:43)

Animal and cellular models demonstrate that creatine metabolism in adipose tissue stimulates cellular thermogenesis and metabolic rate through the futile creatine cycle (FCC) and enhances mitochondrial respiration in brown and beige adipocytes, which can lead to increased energy expenditure in rodent models.

1:04:44Darren Candowsupportedhigh

A daily dose of 3 grams of creatine can saturate skeletal muscle within 30 days.

"But again, 3 g could saturate your skeletal muscle in 30 days, so it's not that long of a wait." (said at 1:04:44)

The seminal trial on muscle creatine loading by Hultman et al. (PMID 8828669) demonstrated that taking a low daily dose of 3 g of creatine leads to a gradual ~20% increase in total skeletal muscle creatine concentration over 28 days, achieving the same tissue saturation levels as a rapid loading protocol (20 g/day for 6 days).

  • supports: Muscle creatine loading in men. (Journal of applied physiology (Bethesda, Md. : 1985) 1996) · cited 815x in the literature
    "A similar, but more gradual, 20% increase in muscle total creatine concentration was observed over a period of 28 days when supplementation was undertaken at a rate of 3 g/day. In conclusion, a rapid way to "creatine load" human skeletal muscle is to ingest 20 g of creatine for 6 days. This elevated tissue concentration can then be maintained by ingestion of 2 g/day thereafter. The ingestion of 3 g creatine/day is in the long term likely to be as effective at raising tissue levels as this higher dose." (abstract, results and conclusions, passage verified)
    pubmedfull study (doi)
1:05:45Darren Candowsupportedmoderate

In a German sleep deprivation study, a single bolus megadose of creatine improved performance on multiple tests following 21 hours of sleep deprivation.

"But on the sleep deprivation study from Germany, they just gave it one bolus mega dose for 21 hours of sleep deprivation, and those individuals did perform better from a number of tests like this the next day." (said at 1:05:45)

A 2024 study conducted by researchers in Germany (Forschungszentrum Jülich, published in Scientific Reports) evaluated the effect of a single high dose of creatine monohydrate (0.35 g/kg body weight) administered during 21 hours of sleep deprivation. The randomized, double-blind study found that acute high-dose creatine attenuated cognitive decline, improved processing speed, and altered cerebral high-energy phosphate metabolism across multiple cognitive assessments. A subsequent 2026 follow-up confirmed similar improvements across logical, numerical, and psychomotor vigilance tasks.

1:07:48Darren Candowsupportedvery low

Evidence in rodents shows that taking creatine prior to head trauma accelerates concussion recovery.

"So, there's evidence in rodents that if you take creatine before head trauma, it really speeds up concussion recovery." (said at 1:07:48)

The speaker specifically attributed the finding to rodent evidence. Preclinical rodent studies demonstrate that dietary supplementation with creatine prior to experimental traumatic brain injury significantly reduces cortical tissue damage (by up to 36% in mice and 50% in rats) and preserves mitochondrial bioenergetics and ATP levels, mitigating injury severity and supporting recovery. Because this finding is based on animal models, the GRADE certainty for human application remains very low.

2 No source found (not proven false)
0:11:41Darren Candowunverifiedvery low

Skeletal muscle accounts for approximately 50% of total lean body mass.

"We think of lean mass, most people think of it as muscle, but lean mass in our body that includes water, connective tissue, organs, as well as skeletal muscle. And about 50% of our lean mass is muscle." (said at 0:11:41)

No published records directly evaluating or quantifying the precise proportion of skeletal muscle relative to total lean body mass or fat-free mass were successfully fetched within the search limit. As a result, the specific figure of approximately 50% could not be formally verified against a fetched publication record.

1:07:48Darren Candowunverifiedlow

Creatine was discovered in 1832.

"So, I'm fascinated that this nutrient, which was, you know, 1832 it was discovered, boring for the longest time because we thought we knew everything" (said at 1:07:48)

Although it is well documented in historical chemistry literature that French chemist Michel Eugène Chevreul discovered creatine in meat extracts in 1832 (naming it from the Greek 'kreas' for flesh), the indexed abstracts retrieved during the search focus on creatine's physiological and nutritional roles rather than its historical discovery date. Consequently, no retrieved abstract containing the verbatim historical discovery date could be cited.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.